Annual Net Income
-$35.14 M
+$2.59 M+6.86%
December 31, 2023
Summary
- As of March 10, 2025, TCRT annual net profit is -$35.14 million, with the most recent change of +$2.59 million (+6.86%) on December 31, 2023.
- During the last 3 years, TCRT annual net income has risen by +$44.84 million (+56.06%).
- TCRT annual net income is now -87970.18% below its all-time high of -$39.90 thousand, reached on December 31, 2002.
Performance
TCRT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$1.13 M
+$2000.00+0.18%
September 30, 2024
Summary
- As of March 10, 2025, TCRT quarterly net profit is -$1.13 million, with the most recent change of +$2000.00 (+0.18%) on September 30, 2024.
- Over the past year, TCRT quarterly net income has stayed the same.
- TCRT quarterly net income is now -112.47% below its all-time high of $9.04 million, reached on June 30, 2010.
Performance
TCRT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$11.78 M
+$7.35 M+38.42%
September 30, 2024
Summary
- As of March 10, 2025, TCRT TTM net profit is -$11.78 million, with the most recent change of +$7.35 million (+38.42%) on September 30, 2024.
- Over the past year, TCRT TTM net income has stayed the same.
- TCRT TTM net income is now -40384.54% below its all-time high of -$29.10 thousand, reached on June 30, 2000.
Performance
TCRT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TCRT Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.9% | 0.0% | 0.0% |
| 3 y3 years | +56.1% | +95.0% | +86.9% |
| 5 y5 years | +33.8% | +94.5% | +83.8% |
TCRT Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.4% | at high | +90.4% | at high | +85.0% |
| 5 y | 5-year | at high | +70.2% | at high | +95.0% | at high | +90.7% |
| alltime | all time | <-9999.0% | +78.7% | -112.5% | +99.1% | <-9999.0% | +93.1% |
Alaunos Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.13 M(-0.2%) | -$11.78 M(-38.4%) |
| Jun 2024 | - | -$1.13 M(-32.9%) | -$19.13 M(-28.6%) |
| Mar 2024 | - | -$1.68 M(-78.6%) | -$26.77 M(-23.8%) |
| Dec 2023 | -$35.14 M(-6.9%) | -$7.84 M(-7.5%) | -$35.14 M(-3.6%) |
| Sep 2023 | - | -$8.48 M(-3.4%) | -$36.46 M(-1.0%) |
| Jun 2023 | - | -$8.77 M(-12.7%) | -$36.83 M(-3.1%) |
| Mar 2023 | - | -$10.05 M(+9.7%) | -$37.99 M(+0.7%) |
| Dec 2022 | -$37.73 M(-52.1%) | -$9.16 M(+3.5%) | -$37.73 M(-6.5%) |
| Sep 2022 | - | -$8.85 M(-10.9%) | -$40.37 M(-25.6%) |
| Jun 2022 | - | -$9.93 M(+1.5%) | -$54.25 M(-19.0%) |
| Mar 2022 | - | -$9.79 M(-17.0%) | -$66.98 M(-14.9%) |
| Dec 2021 | -$78.75 M(-1.5%) | -$11.79 M(-48.1%) | -$78.75 M(-12.2%) |
| Sep 2021 | - | -$22.73 M(+0.3%) | -$89.73 M(+2.8%) |
| Jun 2021 | - | -$22.67 M(+5.2%) | -$87.31 M(+4.9%) |
| Mar 2021 | - | -$21.55 M(-5.3%) | -$83.24 M(+4.1%) |
| Dec 2020 | -$79.98 M(-32.1%) | -$22.77 M(+12.1%) | -$79.98 M(+9.6%) |
| Sep 2020 | - | -$20.32 M(+9.2%) | -$72.95 M(-42.4%) |
| Jun 2020 | - | -$18.60 M(+1.7%) | -$126.63 M(+3.2%) |
| Mar 2020 | - | -$18.29 M(+16.2%) | -$122.66 M(+4.1%) |
| Dec 2019 | -$117.80 M(+121.8%) | -$15.75 M(-78.7%) | -$117.80 M(+2.9%) |
| Sep 2019 | - | -$74.00 M(+406.1%) | -$114.53 M(+115.6%) |
| Jun 2019 | - | -$14.62 M(+8.8%) | -$53.12 M(+5.1%) |
| Mar 2019 | - | -$13.43 M(+7.6%) | -$50.53 M(-4.9%) |
| Dec 2018 | -$53.12 M(-2.2%) | -$12.48 M(-0.8%) | -$53.12 M(-1.5%) |
| Sep 2018 | - | -$12.59 M(+4.6%) | -$53.91 M(-0.2%) |
| Jun 2018 | - | -$12.03 M(-24.9%) | -$54.02 M(-1.5%) |
| Mar 2018 | - | -$16.02 M(+20.7%) | -$54.86 M(+1.0%) |
| Dec 2017 | -$54.32 M(-67.1%) | -$13.27 M(+4.5%) | -$54.32 M(+3.9%) |
| Sep 2017 | - | -$12.70 M(-1.3%) | -$52.27 M(+3.7%) |
| Jun 2017 | - | -$12.86 M(-16.9%) | -$50.43 M(-70.1%) |
| Mar 2017 | - | -$15.49 M(+38.0%) | -$168.76 M(+2.1%) |
| Dec 2016 | -$165.30 M(+37.6%) | -$11.22 M(+3.4%) | -$165.30 M(+1.1%) |
| Sep 2016 | - | -$10.85 M(-91.7%) | -$163.55 M(-4.3%) |
| Jun 2016 | - | -$131.20 M(+991.6%) | -$170.87 M(+217.1%) |
| Mar 2016 | - | -$12.02 M(+26.8%) | -$53.88 M(-55.1%) |
| Dec 2015 | -$120.09 M(+277.9%) | -$9.48 M(-47.8%) | -$120.09 M(-0.8%) |
| Sep 2015 | - | -$18.17 M(+27.9%) | -$121.01 M(+11.1%) |
| Jun 2015 | - | -$14.21 M(-81.8%) | -$108.94 M(+8.6%) |
| Mar 2015 | - | -$78.23 M(+652.1%) | -$100.30 M(+215.6%) |
| Dec 2014 | -$31.78 M(-44.3%) | -$10.40 M(+70.7%) | -$31.78 M(+4.9%) |
| Sep 2014 | - | -$6.09 M(+9.3%) | -$30.28 M(-26.0%) |
| Jun 2014 | - | -$5.58 M(-42.6%) | -$40.90 M(-24.3%) |
| Mar 2014 | - | -$9.71 M(+9.1%) | -$54.02 M(-5.4%) |
| Dec 2013 | -$57.11 M(-40.6%) | -$8.90 M(-46.7%) | -$57.11 M(-27.2%) |
| Sep 2013 | - | -$16.71 M(-10.6%) | -$78.43 M(-1.4%) |
| Jun 2013 | - | -$18.69 M(+46.0%) | -$79.54 M(-5.8%) |
| Mar 2013 | - | -$12.80 M(-57.7%) | -$84.46 M(-12.1%) |
| Dec 2012 | -$96.13 M | -$30.23 M(+69.6%) | -$96.13 M(+21.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$17.82 M(-24.5%) | -$79.15 M(+27.4%) |
| Jun 2012 | - | -$23.61 M(-3.5%) | -$62.13 M(+26.2%) |
| Mar 2012 | - | -$24.47 M(+84.8%) | -$49.24 M(-22.8%) |
| Dec 2011 | -$63.78 M(+95.2%) | -$13.24 M(+1551.4%) | -$63.78 M(+2.2%) |
| Sep 2011 | - | -$802.00 K(-92.5%) | -$62.38 M(-15.5%) |
| Jun 2011 | - | -$10.72 M(-72.5%) | -$73.79 M(+36.6%) |
| Mar 2011 | - | -$39.01 M(+229.2%) | -$54.02 M(+65.4%) |
| Dec 2010 | -$32.67 M(+327.1%) | -$11.85 M(-2.9%) | -$32.67 M(+64.5%) |
| Sep 2010 | - | -$12.21 M(-235.0%) | -$19.86 M(+88.6%) |
| Jun 2010 | - | $9.04 M(-151.2%) | -$10.53 M(-52.1%) |
| Mar 2010 | - | -$17.65 M(-1931.2%) | -$21.96 M(+187.1%) |
| Dec 2009 | -$7.65 M(-69.7%) | $964.00 K(-133.5%) | -$7.65 M(-41.9%) |
| Sep 2009 | - | -$2.88 M(+19.8%) | -$13.18 M(-16.8%) |
| Jun 2009 | - | -$2.40 M(-28.2%) | -$15.85 M(-20.6%) |
| Mar 2009 | - | -$3.34 M(-26.8%) | -$19.95 M(-20.9%) |
| Dec 2008 | -$25.23 M(-5.2%) | -$4.56 M(-17.7%) | -$25.23 M(-11.1%) |
| Sep 2008 | - | -$5.54 M(-14.7%) | -$28.37 M(-5.9%) |
| Jun 2008 | - | -$6.50 M(-24.6%) | -$30.15 M(-0.1%) |
| Mar 2008 | - | -$8.62 M(+12.0%) | -$30.19 M(+13.5%) |
| Dec 2007 | -$26.61 M(+49.0%) | -$7.70 M(+5.1%) | -$26.61 M(+7.6%) |
| Sep 2007 | - | -$7.32 M(+11.9%) | -$24.73 M(+18.5%) |
| Jun 2007 | - | -$6.55 M(+29.8%) | -$20.86 M(+6.0%) |
| Mar 2007 | - | -$5.04 M(-13.4%) | -$19.68 M(+10.2%) |
| Dec 2006 | -$17.86 M(+87.6%) | -$5.82 M(+68.4%) | -$17.86 M(+23.2%) |
| Sep 2006 | - | -$3.45 M(-35.6%) | -$14.50 M(+5.0%) |
| Jun 2006 | - | -$5.36 M(+66.7%) | -$13.81 M(+31.8%) |
| Mar 2006 | - | -$3.22 M(+30.8%) | -$10.48 M(+10.1%) |
| Dec 2005 | -$9.52 M(+67.3%) | -$2.46 M(-11.0%) | -$9.52 M(-1.8%) |
| Sep 2005 | - | -$2.77 M(+36.3%) | -$9.69 M(+17.1%) |
| Jun 2005 | - | -$2.03 M(-10.2%) | -$8.27 M(+32.2%) |
| Mar 2005 | - | -$2.26 M(-14.1%) | -$6.26 M(+56.3%) |
| Dec 2004 | -$5.69 M(+3452.3%) | -$2.63 M(+95.1%) | -$4.00 M(+165.7%) |
| Sep 2004 | - | -$1.35 M(+8223.5%) | -$1.51 M(+805.2%) |
| Jun 2004 | - | -$16.20 K(+145.5%) | -$166.40 K(+6.1%) |
| Mar 2004 | - | -$6600.00(-95.1%) | -$156.80 K(-2.1%) |
| Dec 2003 | -$160.10 K(+301.3%) | -$135.10 K(+1489.4%) | -$160.10 K(+347.2%) |
| Sep 2003 | - | -$8500.00(+28.8%) | -$35.80 K(+5.6%) |
| Jun 2003 | - | -$6600.00(-33.3%) | -$33.90 K(-16.7%) |
| Mar 2003 | - | -$9900.00(-8.3%) | -$40.70 K(+1.8%) |
| Dec 2002 | -$39.90 K(-45.0%) | -$10.80 K(+63.6%) | -$40.00 K(-42.5%) |
| Sep 2002 | - | -$6600.00(-50.7%) | -$69.60 K(-0.4%) |
| Jun 2002 | - | -$13.40 K(+45.7%) | -$69.90 K(+2.3%) |
| Mar 2002 | - | -$9200.00(-77.2%) | -$68.30 K(-5.8%) |
| Dec 2001 | -$72.50 K | -$40.40 K(+485.5%) | -$72.50 K(+125.9%) |
| Sep 2001 | - | -$6900.00(-41.5%) | -$32.10 K(-40.9%) |
| Jun 2001 | - | -$11.80 K(-11.9%) | -$54.30 K(-24.2%) |
| Mar 2001 | - | -$13.40 K(-54.0%) | -$71.60 K(+23.0%) |
| Sep 2000 | - | -$29.10 K(0.0%) | -$58.20 K(+100.0%) |
| Jun 2000 | - | -$29.10 K | -$29.10 K |
FAQ
- What is Alaunos Therapeutics annual net profit?
- What is the all time high annual net income for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual net income year-on-year change?
- What is Alaunos Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly net income year-on-year change?
- What is Alaunos Therapeutics TTM net profit?
- What is the all time high TTM net income for Alaunos Therapeutics?
- What is Alaunos Therapeutics TTM net income year-on-year change?
What is Alaunos Therapeutics annual net profit?
The current annual net income of TCRT is -$35.14 M
What is the all time high annual net income for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual net profit is -$39.90 K
What is Alaunos Therapeutics annual net income year-on-year change?
Over the past year, TCRT annual net profit has changed by +$2.59 M (+6.86%)
What is Alaunos Therapeutics quarterly net profit?
The current quarterly net income of TCRT is -$1.13 M
What is the all time high quarterly net income for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly net profit is $9.04 M
What is Alaunos Therapeutics quarterly net income year-on-year change?
Over the past year, TCRT quarterly net profit has changed by $0.00 (0.00%)
What is Alaunos Therapeutics TTM net profit?
The current TTM net income of TCRT is -$11.78 M
What is the all time high TTM net income for Alaunos Therapeutics?
Alaunos Therapeutics all-time high TTM net profit is -$29.10 K
What is Alaunos Therapeutics TTM net income year-on-year change?
Over the past year, TCRT TTM net profit has changed by $0.00 (0.00%)